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Background: Alveolar ridge resorption, as a significant problem in implant and
restorative dentistry, has long been considered as an inevitable outcome following
tooth extraction. Recently, adrenomedullin (ADM) is reported to be able to stimulate
the proliferation and migration of various cells including osteoblasts. The purpose of
this study was to investigate the influence of local ADM application in the tooth
extraction socket in vivo.
Methods: Chitosan micropheres were developed by an emulsion-ionic cross-linking
method for ADM delivery. Poly (L -lactic-co-glycolic) acid (PLGA) and nano-
hydroxyapatite (nHA) were used to prepare scaffolds to contain the micrspheres with
ADM. In vivo experiment was evaluated by transplanting the composite into the rat
socket right after the incisor extraction. After 4, 8, 12 weeks implantation,
radiographic and histological tests were carried out to evaluate the effect of released
ADM on the alveolar bone.
Results: The microspheres had a spherical structure and a relative rough and
uniform surface, and the particle size was under a normal distribution, with the
average diameter of 38.59 μm. The scaffolds had open and interconnected pores. In
addition, the high porosity of the composite was 88.93%. Radiographic and
histological examination revealed that the PLGA/nHA/CMs/ADM composite could
accelerate the alveolar bone remodeling and reduce the residual ridge resorption
compared with the PLGA/nHA/CMs scaffold.
Conclusions: The results of this study suggest that local application of ADM has the
potential to preserve the residual alveolar ridge and accelerate the alveolar bone
remodeling.
Keywords: Poly (lactic-co-glycolic) acid, Microsphere, Adrenomedullin, Alveolar bone
loss, Bone regenerationBackground
Nowadays, the dental implant is accepted as a promising approach to replace a single
tooth or multiple adjacent missing teeth, or to support a removable prosthesis. The
classic theory holds a veiw that the interval time between tooth extraction and implant
placement is three months, when the bone condition is insufficient for immediate© 2013 Wang et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
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place following tooth extraction, which is termed residual ridge resorption. Residual
ridge resorption is a common and incapacitating problem, particularly for persons with
edentulous aesthetic areas and posterior mandibles. It often leads to a lack of sufficient
support for implant placement. The quest for socket preservation is one of the major
focuses in order to achieve optimum esthetics and function with implant restorations.
Many approaches [1-3] including autograft and allograft have been attempted. How-
ever, secondary lesions, short in supply and poor long-term results of these treatments
limit their clinical applications [4].
Bone tissue engineering for some time has been considered as a promising alternative
approach to autologous bone graft. Artificial bone scaffold for clinic is designed to
mimic native extracellular matrix as closely as possible in term of structure and func-
tion [5]. Poly (lactic-co-glycolic) acid, short for PLGA, was one of the most widely used
biodegradable polymers for scaffold because of its good biocompatibility and control-
lable degradation rate. However, PLGA is hydrophobic and lack of a cell-recognizing
signal surface. The combination of PLGA and a natural polymer, such as hydroxyapa-
tite might overcome some of the limitations [6]. Chitosan has been widely used for the
controlled delivery of peptides or proteins in the format of microspheres, due to its ex-
cellent biological properties such as biodegradability, biocompatibility, non-toxicity,
bacteriostatic and strong adhesion [7].
Recently, the strategies for bone tissue engineering have turned to the application
of cytokines and specific growth factors, such as BMP2, VEGF, for accelerating new
bone formation in vivo via transmitting signal to modulate cellular activities [8]. To
our knowledge, not only osteogenesis, but also angiogenesis is a significant property
for artificial bone scaffold. Therefore, multifunctional growth factors are eargly re-
quired. Adrenomedullin (ADM), as a 52-amino-acid regulatory peptide, was initially
isolated from human pheochromocytoma [9]. It is a member of the CGRP (calci-
tonin gene-related peptide) family because of their structural homology [10]. As
reported [11], ADM is an additional potent mitogen to osteoblasts, stimulating the
proliferation of primary osteoblasts and osteoblast-like cell lines. Moreover, other
significant effects had also been investigated in recent years, such as angiogenesis
[12], and antibacterial effects [13]. CORNISH et al. [14] suggested ADM could
stimulate osteoblast proliferation and increase intracellular Ca2+ levels. Further
study has inferred that ADM-induced proliferation is due to an increase in [Ca2+]i
by facilitation of voltage-dependent Ca2+ channels [15]. Furthermore, RIBATTI
et al. demonstrated that ADM possessed a significant proangiogenic effect [16].
Evidence is accumulating that ADM would be a promising therapeutic agent for
bone formation.
In the present study, PLGA/nHA and chitosan were chosen as carriers for ADM de-
livery to overcome the disadvantage of rapid clearance associated with the use of ADM.
Firstly, chitosan microspheres (CMs) loaded with ADM were prepared by an emulsion-
ionic cross-linking method. Afterwards, CMs with ADM was embedded into PLGA/
HA scaffolds by thermally induced phase separation. The purpose of present study was
to investigate the effects of local application of ADM in a rat model on alveolar bone
rebuilding following incisor extraction, and the efficiency of microspheres-scaffold
complex as a carrier for this peptide.
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Materials
Chitosan (Mw = 500 kDa) was purchased from Jinqiao Chemical Reagents Company
(Taizhou, Zhejiang, China). Human adrenomedullin (purity=95% by HPLC) was
obtained from Phoenix Pharmaceuticals (Burlingame, Canada). TPP and span-80 was
got from Aladding (Shanghai, China). PLGA (nLA/nGA=80/20) and nHA were gifts
from Changchun institute of applied chemistry Chinese academy of sciences. Other
chemicals were all analytical grades and used as received.
Preparation and characterization of scaffolds
Chitosan microspheres were fabricated by an emulsion-ionic cross-linking method de-
scribed previously [17]. Briefly, 900 mg of chitosan was dissolved in 29 mL of 2% (v/v)
aqueous acetic acid, stirring overnight at room temperature. Afterwards, 1 mg of ADM
was dissolved in 1 mL of 2% (v/v) acetic acid and added to the chitosan solution. The
mixture was poured into 300 mL of liquid paraffin containing 2% (w/v) of span-80 and
stirred mechanically for 2 h. Then, 70 mL of 5% (w/v) TPP was slowly added in droplet
into the emulsion and stirred for 4 h at room temperature. The microspheres were
obtained by washing with excess amounts of petroleum ether, isopropyl alcohol and
distilled water repeatedly, prior to lyophilization.
Microsphere-scaffold composite was developed by thermally induced phase
separation outlined in Figure 1a. Firstly, 720 mg of PLGA was dissolved in 12 mL of in
1, 4-dioxane. 360 mg of nHA was added into the mixture after stirring for half an hour.
Ultrasonics was used to disperse the nHA completely for 10 min. 240 mg of chitosan
microspheres with ADM was added to the above solution subsequently. The mixture wasFigure 1 Schematic illustrations of TPP-chitosan microspheres preparation (a) and microsphere-
scaffold composite fabrication (b). The chitosan microspheres loaded with ADM were prepared by the
emulsion method in the presence of TPP, carrying five negative charges which allows the electrostatic
interaction with positively charged amino group of chitosan in an aqueous acidic solution.
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polytetrafluoroethene plate. Afterwards, the solution was frozen in refrigerator at −20°C
overnight. Finally, PLGA/nHA/CMs/ADM scaffolds were obtained after lyophilized. The
scaffolds without ADM were also prepared in the same manner as control.
The structure of polymer scaffold, as well as chitosan microsphere, was examined by
scanning electron microscopy (SEM, XL30ESEM-FEG, FEL, Netherlands). The size dis-
tribution of microspheres was determined by a SEM-scanning method reported earlier
[18]. Briefly, the size distribution of microspheres was evaluated by a coefficient of vari-
ation (CV), which was calculated by following equation:
CV ¼ SDD  100%
The diameters of chitosan microspheres were evaluated by measuring a random vi-
sion field of 100 microspheres. Where D is the arithmetic average diameter of the total
microspheres, SD stands for the standard deviation of the diameters.
Porosity values of the polymer scaffolds were measured by a modified liquid displace-
ment method [19].
The porous scaffolds were cut into small rods of 15 mm × 2 mm × 1.5 mm. Each rod
was bent to fit the incisor sockets, and sterilized with a 25 kGy Co60 radiation in prep-
aration for in vivo experiment.
In vitro release study
The ADM release profiles from microsphere-scaffold composite were carried out
in vitro at 37°C in 10 mL of a modified stimulated body fluid (SBF) solution dynamic-
ally for 12 weeks. The SBF solution is similar to that recommended previously [20].
The microsphere-scaffold composite with ADM was immersed into the SBF. The re-
lease medium was withdrawn at each predetermined time interval, and replaced with
fresh soaking medium (3 ml) each time. The elution of ADM in release medium was
examined every a week by high performance liquid chromatography system (HPLC,
Waters 2695, Milford, USA). The PLGA/nHA scaffold loading with ADM without chi-
tosan microsperes was set as control. All of the data presented in the figure are the
average data from 6 parallel samples.
Animals and surgical procedures
Fifty-four male Wista rats (8 week old) with average weight 250–300 g were used. The rats
were fed in Jilin University Laboratory Animal Center under similar experimental condi-
tions. The animal protocol for this research was followed by Principles of laboratory animal
care (NIH publication No. 85–23, revised 1985), and approved by the Animal Care and
Utilization Committee of the School of Stomatology, Jilin University as well. Rats were
randomly divided into 3 groups: (1) experimental group (PLGA/nHA/CMs/ADM scaffold
implant after incisor extraction); (2) control group (PLGA/nHA/CMs scaffold implant after
incisor extraction); (3) blank control group (untreated after incisor extraction).
The mandibular right incisor was cut at a gingival level by a small diamond bur at
high speed every three days before extraction under ether anaesthesia. Three days after
last cutting, the right incisor was extracted carefully without any rotation under deep
anesthesia with pentobarbital (40 mg/kg, intramuscular). Afterwards, the PLGA/nHA/
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perimental group and control group, respectively. The blank control group was un-
treated after tooth extraction. The gingiva was closed with sutures. Antibiotic
prophylaxis included 30 mg of penicillin preoperatively and 30 mg a day for 2 postoper-
ative days via recommendation of the veterinarian department.
Radiological examination
The rats were sacrificed at 4, 8, 12 week post-operation under deep anaesthesia. All rats
were perfused via the ascending aorta with saline followed by 4% paraformaldehyde in
0.1 M phosphate buffer (pH 7.4). Thereafter, the mandible was dissected out and fixed
in the same fixative solution for 2 days at 4°C.
Soft X-ray images of the mandibles was taken by soft x-ray radiographic apparatus
(Giotto Image-MD by IMS, Bologna, Italy). The digital imagine was got by scanning
(Epson perfection 4490 photo, Seiko Epson Corp., Nagano, Japan). The distances be-
tween the infradentale point (apex of mandible ridge of incisor) and the highest point
of the mesial alveolar bone at the lower first molar on both side were measured with
Image-Pro Plus software (Media Cybernetics, Silver Springs, MD). The ratio of the
heights on the left and right side was used to determine the residual ridge resorption
on the preservative sites after tooth extraction.
In addition, the bone mineral density (BMD) of mandibular alveolar bone was initially
detected by Dual-energy X-ray absorptiometry (DEXA) for small animals, and then cal-
culated. The area of interest for BMD evaluation was from the anterior edge of alveolar
ridge to the proximal surface of the first molar, since there is no tooth root in this area.
Histological examination
The mandibles were harvested at each predetermined time point. The progress of per-
fusion and fixation of specimens was performed as described above. Thereafter, we
used a 10% ethylenediaminetetraacetic acid (EDTA) solution in PBS for decalcification,
pH 7.4, for a period of 6–8 week at 4°C, depending on degree of mineralization, with
renewal of EDTA every week, before the specimens were dehydrated in a series of alco-
hols, transferred to xylene and embedded in paraffin. Serial transverse sections of tooth
socket (4 μm thick) were prepared for evaluation of newly bone formation. The first
one of every 5 consecutive sections was mounted on a piece of polylysine-coated slide,
and then staining with haematoxylin-eosin.
To investigate the bone formation performance of the developed scaffolds at
in vivo state, histomorphometric measurement was performed under a DM 4000
light microscopy (Leica, Germany) using an image analysis program (Leica Q VIN3
Software). The following parameters were measured: Dimensions of total defect area
and newly formed bone. The percentage of values also were obtained in relation to
the total defect area:
Newly Formed Bone NFB%ð Þ ¼ New bone area=Total defect area 100%
Statistical analysis
All values were expressed the mean ± standard deviation (SD). Statistical analyses were
carried out using SPSS 17.0 for Windows (SPSS Inc., Chicago, IL, USA). The statistical
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nificant values were defined as P < 0.05.
Results
Characterization of chitosan microspheres and PLGA/nHA/CMs scaffolds
Chitosan microspheres were prepared in presence of TPP by ionic cross-linking between
a carrying five-negative-charge TPP and a positively charged amino group of chitosan in
anaqueous acidic solution (Figure 1b). The surface morphology of chitosan microspheres
with ADM was shown in Figure 2a. The microspheres had preferably a spherical structure
spherical in sharp and a relative rough and uniformity surface without any hollow and
crack. The diameters of CMs were obtained by measuring a random vision field of 100
microspheres from SEM images. The CV was 0.394, indicating a uniform size distribution.
Moreover, as shown in Figure 3 combining with Figure 2a, the size of most microspheres
varied from 8 μm to 75 μm. The particle size distribution also confirmed to a normal dis-
tribution, with the average diameter of (38.59±15.20) μm.
The morphology of PLGA/nHA scaffolds with ADM-CMs incorporation was shown
in Figure 2b. The SEM image showed the CMs were distributed all across the PLGA/
nHA matrix. The scaffolds were seen to have open and interconnected pores. Further-
more, most of pore sizes of the scaffolds were located between 50 μm and 220 μm. In
addition, the porosity of PLGA/nHA/CMs/ADM was (88.93±0.32) %.In vitro release kinetics of ADM
The release kinetics of ADM from PLGA/nHA/CMs and PLGA/nHA porous scaffold
was depicted in Figure 4a and 4b. The release behavior of ADM from scaffold with chi-
tosan microspheres tended to be a sustained linear manner during the first 8 week after
an initial burst at 1 week, followed by a slow and stable manner from 8th week. As a
result, the final amount of released ADM out of scaffolds was 68.94% within the whole
stages. However, an initial burst of 74.8% was appeared at day 1 in the control group,
followed by a plateau with a final cumulative release of 79.6% at day 7.Relative height of residual alveolar ridge
The distance of interest was used to evaluate the relative height of residual alveolar
ridge (Figure 5). Relative height values of residual alveolar ridge in all groups wereFigure 2 SEM images of chitosan microspheres with ADM (a) and PLGA/nHA scaffold (b) prepared
in presence of CMs-ADM. The arrows show the chitosan microspheres (white) and nHA (black) in
the scaffold.
Figure 3 The size distribution of chitosan microspheres with ADM loading. The diameter of the
microspheres was ranged from 8 μm to 75 μm, which confirmed to a normal distribution.
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mandibles at predetermined times. The values in the experimental group were signifi-
cantly higher compared with those of the other two groups at 4, 8, 12 week post-
operation. Meanwhile, the values of the control group were significantly higher com-
pared with those of blank control group at 8, 12 week post-operation.Bone density examination
The BMD values in different groups were presented in Table 2. Corresponding to the Soft
X-ray images (Figure 5), BMD values appeared no difference among the three groups. At
8 week post-operation, the values were significantly higher in the experimental group and
control group than blank control group. At 12 week post-operation, only BMD value in
the experimental group was significantly higher than the other two groups.Figure 4 In vitro release of ADM from PLGA/nHA/CMs scaffold (a) and PLGA/nHA scaffold (b) in SBF
solution.
Figure 5 Soft X-ray images of mandibles at each predetermined time. The morphometric
measurement on residual alveolar ridge by radiation is focused on the distance between apex of mandible
ridge of incisor and the highest point of the mesial alveolar bone of first molar, just as the arrow showed.
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Histological evaluation was performed with HE staining of tooth extraction socket in
mandible including the different implanted scaffolds, and the result was shown in
Figure 6. At 4 week post-operation, mild inflammatory reaction was found in tooth
socket in all groups. The tooth socket was fully filled with fibrous tissue. The scaffolds
with a little tissue ingrowth were observed to be encapsulated by a connective tissue
layer which was composed of fusiform stroma cells, macrophages, inflammatory cells
and extracellular matrix. Only a layer of primary trabecular bone at the margin of the
tooth socket was observed (Figure 6a, 6b, 6c). At 8 week post-operation, the PLGA/
nHA/CMs with ADM was repalced by creeping substitution and a lot of fibrous callus
appeared in the tooth extraction socket. More newly formed bone which tended to
penetrate into the scaffold was found, and the scaffold was degraded into fragmental
pieces as well (Figure 6d). In contrast, less primary bone was observed in the boundary
area between the scaffold and alveolar bone in the control group. The scaffold sur-
rounding with a dense cell layer was still occupied the defect regions (Figure 6e). Fur-
thermore, although there exsited inflammatory cell infiltration, the newly formed bone
was more mature in blank control group (Figure 6f ). At 12 week post-operation, the
scaffold appeared an obvious degradation accompanied with the new bone formation.
Especially in experimental group, bone islands, which were fused to the original bone
around the defect, formed in the defect areas. In addition, bone lacunae, which is a
mark of the new bone formation contained osteocyte-like cells, were also appeared.
The texture of bone trabecula was remarkably clearer than that in thw control group
(Figure 6g). On the contrary, a large amount of original osseous callus formed in the
tooth socket, and yet the space with scaffold occupied also exsited in the control group
(Figure 6h). Moreover, in the blank control group, the inflammory cell infiltration was
disappeared, while massive mature newly formed bone grown into the center of the




Experimental group Control group Blank control group
4 0.9890 ±0.0079*# 0.9651 ±0.0075 0.9612 ±0.0126
8 0.9828 ±0.0093*# 0.9495 ±0.0116# 0.9317 ±0.0103
12 0.9579 ±0.0101*# 0.9213 ±0.0166# 0.8992 ±0.0155
Values are expressed as means ± SD (n = 6). *p < 0.05, significantly different compared with control group, # p < 0.05,
significantly different compared with blank control group.
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(Figure 6i).
In order to quantity the bone formation performance of the scaffolds at in vivo state,
histomorphometric test was carried out. The results were shown in Figure 7. In terms
of osteoid formation, the statistically significant differences were appeared in PLGA/
nHA/CMs/ADM group and blank control group compared with PLGA/nHA/CMs
group at week 8 and 12. Meanwhile, the value of the experimental group was signifi-
cantly higher than that of blank control group at week 12 post-operation.
Discussion
Due to the adrenomedullin’s short clearance time in vivo, a controlled delivery system
was developed to load it. Although there was a report that PLGA scaffold solely could
be used for protein controlled delivery [21], PLGA/nHA scaffold loading with ADM
leads to an initial burst of 74.8% during the first day in our study. Therefore, chitosan
microsphere was introduced into PLGA/nHA scaffold to be a newly microsphere-
scaffold delivery system. Chitosan microspheres loading with ADM were prepared by
an emulsion-ionic cross-linking method in presence of TPP. Unlike chemical cross-
linking, this method can help to to avoid negative effects for proteins and peptides.
Cross-linking time is critical to formation of microspheres, because the combination of
TPP molecules with microspheres is time-dependent. If the cross-linking time is not
long enough, only fragile microspheres with irregular surface will be obtained. Micro-
spheres under a normal distributed size with an average of 38.59 μm might be suitable
for further usage in PLGA/nHA scaffold. PLGA as a biodegradable material has been
used as bone regenerative materials in surgery for a long time. An ideal porosity of
more than 80% is a distinct symbol of a perfect scaffold [22]. The high porosity of
PLGA/nHA/CMs/ADM was perhaps a consequence of an interconnected three-
dimensional pore structure. A pivotal study by ELEMA et al. [23] showed that optimal




Experimental group Control group Blank control group
4 62.80±3.80 60.97±5.28 59.89±2.25
8 81.72±3.22 *# 75.91±1.20# 69.83±1.98
12 93.10±1.80*# 88.08±1.23 86.33±1.31
Values are expressed as means ± SD (n = 6). *p < 0.05, significantly different compared with control group. # p < 0.05,
significantly different compared with blank control group.
Figure 6 Histological images by HE-stained tissue sections of tooth socket at different times after
implanting operation. (a, d, and g) the PLGA/nHA/CMs/ADM group (4, 8, and 12 weeks, respectively);
(b, e, and h) the PLGA/nHA/CMs group (4, 8, and 12 weeks, respectively); (c, f, and i) the blank control
group (4, 8, and 12 weeks, respectively); NB: newly formed bone, SW: socket wall, SO: tooth socket, IC:
inflammatory cells filtration, Arrows indicate bone lacuna. The scale bar: 50 μm.
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large a size would decrease the local medicine concentration. In this study, open and
interconnected pores with size ranged from 50 μm to 220 μm were established by ther-
mally induced phase separation, which provided a large surface area to allow cell attach-
ment and facilitated nutrient and waste exchange by cells deep within the construct.
Furthermore, the pore size within the optimal range was suitable for cell penetration.
The release behavior of ADM from scaffold with chitosan microspheres tended to be
a sustained linear manner during the first 8 week, followed by a slow and stable man-
ner to 12th week. The plasma half-life of ADM has been reported to be 22.0±1.6 min
[24], and corresponding to the release profile and total amout of ADM, the released
ADM concentration would maintain at 1 nM, which could be optimal to osteoblast
proliferation in vitro. The initial burst release in the first week may due to the physical
absorption of ADM on the scaffold surface. This microsphere-scaffold delivery carrier
could maximize the effect of ADM by maintaining the local peptide concentration at a
designed level for a longer period according to continuous and sustained release. The
PLGA/nHA/CMs microsphere-scaffold system has several superiorities as follows:
Firstly, the nHA played a role in mimicking the nanostructure of natural bone. Sec-
ondly, alkaline dissolution of the chitosan microsphere could neutralize the degraded
acidic molecules of PLGA, which might decrease the negative effect of PLGA degrad-
ation. Moreover, the progress of making microsphere-scaffold carrier is non-toxic,
which could preserve the bioactivity of the introduced peptides and proteins.
Figure 7 Bone formation areas of various scaffolds at 4, 8 and 12 weeks after implantation. Mean
values were compared by ANOVA and were significantly different at P<0.05. *statistically significant different
compared with PLGA/nHA/CMs group. #statistically significant different compared with blank control group.
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scaffold carriers would be potent for further in vivo studies.
Bone formation process is a complicated cascade that relies on several mechanisms
including synthesis of matrix proteins and calcium phosphate. The synthesis happens
in a continuously renewed biological environment and is regulated by a cluster of
growth factors [25]. ADM has been shown to induce angiogenesis in vitro and in vivo,
which is essential to bone formation in tissue engineering [26,27]. However, the effect
of ADM on bone resorption is controversial: GONZALEZ et al. documented that
ADM treatment could inhibit the osteoclast-mediated activity [28], whereas others
failed to observe any reduction in bone resorption when ADM was administered either
locally or systemically [29,30]. To be sure, ADM is a potent osteoblast mitogen at a
physiological concentration of 1 pM or greater.
The height and width of the residual alveolar ridge would decrease following tooth ex-
traction. The morphometric analyses demonstrated that the relative height of the experi-
mental group was significantly higher than that of the other groups at 4, 8, 12 week,
which inferred that ADM could have effects on reducing the residual ridge resorption at
the early stage. Also, the values of control group were significantly higher than those in
blank control group at 8, 12 week. Perhaps, the PLGA/nHA/CMs can also maintain the
relative height of residual ridge by its excellent osteoconductivity. Its effect on resorption
prevention, however, is clearly weaker than the scaffold with ADM. It is logical to presume
that ADM may contribute to the preservation of alveolar bone at tooth extraction site.
Bone mineral density (BMD) is an important index for assessing the amount of bone
formation, as well as the degree of calcification of newly formed bone. Dual energy X-ray
absorptiometry (DEXA) is currently the most widely used technique for bone loss meas-
urement, and even has been an established standard for measuring bone mineral density.
In the present study, DEXA analyses showed that the BMD of alveolar bone in experi-
mental group was no significantly difference compared with the other two groups at
4 week, following with a distinct increasing at 8 ,12 week, which was significantly higher
than the other groups. Apparently, functional occlusion is crucial for preserving the
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control group would decrease conspicuously, whereas the presence of an osteoconductive
bioactive scaffold can support the contour of the socket and allow osteoblasts to migrate
to form bone more efficiently within the extraction space, which facilitates bone healing
[31]. Interestingly, BMD was also higer in the experimental group at 12 week, correspond-
ing to the ADM release profile, indicating that even if the releasing of ADM almost
stopped, the higher BMD was still maintained, possibly because of the different release be-
havior between in vivo and in vitro. This different release behavior in vivo compared to
in vitro was due to the enzymes, liposomes, germs and phagocytes in vivo.
To get a further insight, we were aimed to study the histological features of the tooth ex-
traction socket. The physiological healing of tooth extraction socket is a complicated dy-
namic progress, beginning with a cascade of inflammatory reactions activated immediately
after tooth extraction and ending with fully muture hard tissue formed in the tooth socket.
Just as shown in blank control group, it occurs as five different stages, including the coagu-
lum of blood cells, orgnization of blood clot and formation of granulation tissue, connect-
ive tissue replacement, start of calcification and mineral tissue deposition. Evidence has
accumulated that most artificial scaffolds were effective for ridge preservation [32,33]. In
the present study, there was no statistically significant difference among the three groups
at 4 week post-operation according to the histomorphometric analysis, which was consist-
ent with the BMD measurement. The graft material had no obvious degradation in the first
4 weeks. 8 weeks post-operation, significant differences have been observed in PLGA/
nHA/CMs/ADM group and blank control group compared with the PLGA/nHA/CMs
group. More mineral tissues and less inflammatory reactions were founed in PLGA/nHA/
CMs/ADM group, while few primary bone was found in PLGA/nHA/CMs group. It
inferred that PLGA/nHA/CMs scaffold had good osteoconductivity, but might lack of
osteoinductivity in its current format. The ADM incorporation might enhance the
osteoinductivity of the scaffold. ADM has been reported to function on not only inducing
the formation of granulation but also improving local circulation, with the result of having
angiogenesis accelerated [34,35], which is crucial in the bone healing process. The similar
tendency of new bone histomorphometric analysis was appeared at 12 weeks after oper-
ation. However, the new bone formation area of the PLGA/nHA/CMs/ADM group was
significantly higher than that of blank control group. Bone islands were discovered in the
PLGA/nHA/CMs/ADM group and blank control group which revealed that ADM could
accelerate bone mineralization and osseous maturation. This result was possibly due to the
microsphere-scaffold system offered a suitable micro-environment for cell growth and tis-
sue formation. It is hypothesized that the biomechanical similarity between PLGA scaffolds
and human cancellous bone, could have contributed to in vivo osteogenesis, by providing a
suitable environment for stem cells to differentiate into the osteogenic lineage. On the
whole, the osteogenic effect in the experimental group was quick in speed and large in
amount. As a result, the microsphere-incoporated-into-scaffold design offered a new strat-
egy for local application of growth factors.
Conclusions
In conclusion, this study demonstrated the microsphere-scaffold composite is a satisfac-
tory delivery system for the sustained release of peptides. In addition, local application of
adrenomedullin by microsphere-scaffold composite could enhance the formation of new
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results may relate to the osseogenic and angiogenic properties of adrenomedullin.
ADM may be a potential treatment for prevention of residual alveolar ridge resorp-
tion. Future studies will focus on specifying the signaling for osteoinduction of ADM.
Thus controlled release profiles can be spatio-temporally designed to coordinate with
signal transduction in vivo.
Abbreviations
ADM: Adrenomedullin; PLGA: Poly (lactic-co-glycolic) acid; nHA: Nano-hydroxyapatite; CMs: Chitosan microspheres;
TPP: Tri-polyphosphate sodium; PBS: Phosphate buffered saline; SBF: Stimulated body fluid; HPLC: High performance
liquid chromatography; SEM: Scanning electron microscopy; BMD: Bone mineral density; EDTA: Ethylenediamine-
tetraacetic acid; SD: Standard deviation.
Competing interests
No conflict of interests is present. The authors have no financial involvement or interest with any organization or
company about subjects or materials discussed in the paper.
Authors’ contributions
LW carried out the synthsis and characterization of the scaffold-microsphere composite. LZ carried out the animal
exiperiment including the animal model establishment, sample implant and specimen harvest. CL conceived of the
study, and carried out the release behavior of the composite. SD participated in the design of the study and
performed the statistical analysis. LA conceived of the study, and participated in its design and coordination and
helped to draft the manuscript. YZ made substantial contributions to conception and design of this study and gave
final approval of the version to be published. All authors read and approved the final manuscript.
Acknowledgements
The authors sincerely appreciate the financial supports of state key laboratory of oral diseases of China (grant No.
d2009001) and development and reform commission of Jilin province (grant No. 20101935). We also thank Yu Wang,
Pan He, Professor Xuesi Chen and Professor Xiaomeng Li for technical surport and experimental advice.
Author details
1VIP integrated department, Stomatological hospital, Jilin University, Changchun, China. 2Implant center,
Stomatological hospital, Jilin University, 1500# Qinghua Road, Chaoyang District, Changchun, China.
Received: 11 May 2013 Accepted: 18 September 2013
Published: 8 October 2013
References
1. Mardas N, Chadha V, Donos N: Alveolar ridge preservation with guided bone regeneration and a synthetic
bone substitute or a bovine-derived xenograft: a randomized, controlled clinical trial. Clin Oral Implants Res
2010, 21:688–698.
2. Kutkut A, Andreana S, Kim HL, Monaco E Jr: Extraction socket preservation graft before implant placement with
calcium sulfate hemihydrate and platelet-rich plasma: a clinical and histomorphometric study in humans.
J Periodontol 2012, 83:401–409.
3. Sisti A, Canullo L, Mottola MP, Covani U, Barone A, Botticelli D: Clinical evaluation of a ridge augmentation
procedure for the severely resorbed alveolar socket: multicenter randomized controlled trial, preliminary
results. Clin Oral Implants Res 2012, 23:526–535.
4. Wu Z, Liu C, Zang G, Sun H: The effect of simvastatin on remodeling of the alveolar bone following tooth
extraction. Int J Oral Maxillofac Surg 2008, 37:170–176.
5. Jansen JA, Vehof JWM, Ruhe PQ, Kroeze-Deutman H, Kuboki Y, Takita H, Hedberg EL, Mikos AG: Growth factor-
loaded scaffolds for bone engineering. J Control Release 2005, 101:127–136.
6. Mou Z, Zhao L, Zhang Q, Zhang J, Zhang Z: Preparation of porous PLGA/HA/collagen scaffolds with
supercritical CO2 and application in osteoblast cell culture. J Supercrit Fluids 2011, 58:398–406.
7. Varshosaz J: The promise of chitosan microspheres in drug delivery systems. Expert Opin Drug Deliv 2007, 4:263–273.
8. Lee SJ: Cytokine delivery and tissue engineering. Yonsei Med J 2000, 41:704–719.
9. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T: Adrenomedullin: a novel
hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993,
91:553–560.
10. Hinson JP, Kapas S, Smith DM: Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000, 21:138–167.
11. Cornish J, Callon KE, Coy DH, Jiang NY, Xiao L, Cooper GJ, Reid IR: Adrenomedullin is a potent stimulator of
osteoblastic activity in vitro and in vivo. Am J Physiol 1997, 273:E1113–E1120.
12. Ribatti D, Nico B, Spinazzi R, Vacca A, Nussdorfer GG: The role of adrenomedullin in angiogenesis. Peptides 2005,
26:1670–1675.
13. Gröschl M, Wendler O, Topf HG, Bohlender J, Köhler H: Significance of salivary adrenomedullin in the maintenance
of oral health: Stimulation of oral cell proliferation and antibacterial properties. Regul Pept 2009, 154:16–22.
14. Cornish J, Naot D, Reid IR: Adrenomedullin - a regulator of bone formation. Regul Pept 2003, 112:79–86.
15. Tazaki M, Endoh T, Kobayashi H, Nobushima H, Shibukawa Y, Tsumura M, Sato M, Ubaidus S, Sueishi K:
Adrenomedullin facilitates calcium channel currents in osteoblasts. Bull Tokyo Dent Coll 2012, 53:203–206.
Wang et al. BioMedical Engineering OnLine 2013, 12:99 Page 14 of 14
http://www.biomedical-engineering-online.com/content/12/1/9916. Ribatti D, Conconi MT, Nussdorfer GG: Nonclassic endogenous regulators of angiogenesis. Pharmacol Rev 2007, 59:185–205.
17. Wang L, Li CY, Chen YX, Dong SJ, Chen XS, Zhou YM: Poly(lactic-co-glycolic) Acid/Nanohydroxyapatite Scaffold
Containing Chitosan Microspheres with Adrenomedullin Delivery for Modulation Activity of Osteoblasts and
Vascular Endothelial Cells. BioMed Res Int 2013, 2013:530712.
18. Chen ZP, Liu W, Liu D, Xiao YY, Chen HX, Chen J, Li W, Cai H, Li W, Cai BC, Pan J: Development of brucine-
loaded microsphere/thermally responsive hydrogel combination system for intra-articular administration.
J Control Release 2012, 162:628–635.
19. Wan Y, Cao X, Wu Q, Zhang S, Wang S: Preparation and mechanical properties of poly(chitosan-g- DL - lactic
acid) fibrous mesh scaffolds. Polym Adv Technol 2007, 19:114–123.
20. Li H, Chang J: Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite
composite microspheres. J Control Release 2005, 107:463–473.
21. Iino G, Nishimura K, Omura K, Kasugai S: Effects of prostaglandin E1 application on rat incisal sockets. Int J Oral
Maxillofac Implants 2008, 23:835–840.
22. She D, Zhang B, Jin C, Feng Q, Xu Y: Preparation and in vitro degradation of porous three-dimensional silk
fibroin/chitosan scaffold. Polym Degrad Stab 2008, 93:1316–1322.
23. Elema H, de Groot JH, Nijenhuis AJ, Pennings AJ, Veth PRH, Klompmaker J, Jansen HWB: Biological evaluation of
porous biodegradable polymer implants in menisci. Colloid Polym Sci 1990, 268:1082–1088.
24. Meeran K, O’Shea D, Upton PD, Small CJ, Ghatei MA, Byfield PH, Bloom SR: Circulating adrenomedullin does not
regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a
pharmacokinetic study. J Clin Endocrinol Metab 1997, 82:95–100.
25. Ai-Aql ZS, Alagl AS, Graves DT, Gerstenfeld LC, Einhorn TA: Molecular mechanisms controlling bone formation
during fracture healing and distraction osteogenesis. J Dent Res 2008, 87:107–118.
26. Harada K, Yamahara K, Ohnishi S, Otani K, Kanoh H, Ishibashi-Ueda H, Minamino N, Kangawa K, Nagaya N, Ikeda T:
Sustained-release adrenomedullin ointment accelerates wound healing of pressure ulcers. Regul Pept 2011, 168:21–26.
27. Tokunaga N, Nagaya N, Shirai M, Tanaka E, Ishibashi-Ueda H, Harada-Shiba M, Kanda M, Ito T, Shimizu W, Tabata Y,
Uematsu M, Nishigami K, Sano S, Kangawa K, Mori H: Adrenomedullin gene transfer induces therapeutic
angiogenesis in a rabbit model of chronic hindlimb ischemia: benefits of a novel nonviral vector, gelatin.
Circulation 2004, 109:526–531.
28. Gonzalez-Rey E, Chorny A, O’Valle F, Delgado M: Adrenomedullin protects from experimental arthritis by down-
regulating inflammation and Th1 response and inducing regulatory T cells. Am J Pathol 2007, 170:263–271.
29. Cornish J, Callon KE, Bava U, Coy DH, Mulvey TB, Murray MA, Cooper GJ, Cooper GJ, Reid IR: Systemic
administration of adrenomedullin(27–52) increases bone volume and strength in male mice. J Endocrinol
2001, 170:251–257.
30. Lerner UH: Deletions of genes encoding calcitonin/a-CGRP, amylin and calcitonin receptor have given new
and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in
bone. J Musculoskelet Neuronal Interact 2006, 6:87–95.
31. Bartee BK: Extraction site reconstruction for alveolar ridge preservation. Part 1: rationale and materials
selection. J Oral Implantol 2001, 27:187–193.
32. Marei MK, Nouh SR, Saad MM, Ismail NS: Preservation and regeneration of alveolar bone by tissue-engineered
implants. Tissue Eng 2005, 11:751–767.
33. Schliephake H, Zghoul N, Jäger V, van Griensven M, Zeichen J, Gelinsky M, Szubtarsky N: Bone formation in trabecular
bone cell seeded scaffolds used for reconstruction of the rat mandible. Int J Oral Maxillofac Surg 2009, 38:166–172.
34. Jin D, Harada K, Ohnishi S, Yamahara K, Kangawa K, Nagaya N: Adrenomedullin induces lymphangiogenesis and
ameliorates secondary lymphoedema. Cardiovasc Res 2008, 80:339–345.
35. Hirakawa S, Detmar M: New insights into the biology and pathology of the cutaneous lymphatic system. J Dermatol
Sci 2004, 35:1–8.doi:10.1186/1475-925X-12-99
Cite this article as: Wang et al.: Adrenomedullin delivery in microsphere-scaffold composite for remodeling of
the alveolar bone following tooth extraction: an experimental study in the rat. BioMedical Engineering OnLine
2013 12:99.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
